Recombinant Human erythropoietin reduces viability of MCF-7 breast cancer cells from 3D culture without caspase activation

Recombinant human erythropoietin (rHuEPO) is the erythropoiesis-stimulating hormone that is being used concurrently with chemotherapeutic drugs in the treatment of anemia of cancer. The effect of rHuEPO on cancer cells in 3-dimensional (3D) cultures is not known. The objective of the study was to de...

Descripción completa

Detalles Bibliográficos
Autores principales: ShujaaEdin, Hareth Y., AL-Haj, Nagi A., Rasedee, Abdullah, Alitheen, Noorjahan Banu, Kadir, Arifah Abdul, How, Chee Wun, Rahman, Heshu Sulaiman, Abdullah, Al-Shwyeh Hussah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071958/
https://www.ncbi.nlm.nih.gov/pubmed/33935571
http://dx.doi.org/10.1016/j.sjbs.2021.01.059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071958/
https://www.ncbi.nlm.nih.gov/pubmed/33935571
http://dx.doi.org/10.1016/j.sjbs.2021.01.059

Ejemplares similares